You have free access to this content

American Journal of Transplantation

Cover image for Vol. 10 Issue 2

February 2010

Volume 10, Issue 2

Pages 196–435

  1. The AJT Report

    1. Top of page
    2. The AJT Report
    3. Editorials
    4. Minireviews
    5. Laboratory Science
    6. Clinical Science
    7. Brief Communications
    8. Case Report
    9. Letters to the Editor
    1. You have free access to this content
      The AJT Report: News and issues that affect organ and tissue transplantation (pages 196–198)

      SUE PONDROM

      Article first published online: 24 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02948.x

      This month, “The AJT Report” examines a new generation of drugs to treat hepatitis C that could change the landscape of liver transplantation. We also take a look at the National Living Donor Assistance Center, and review the CDC's quest for a national transplant safety network.

  2. Editorials

    1. Top of page
    2. The AJT Report
    3. Editorials
    4. Minireviews
    5. Laboratory Science
    6. Clinical Science
    7. Brief Communications
    8. Case Report
    9. Letters to the Editor
    1. You have free access to this content
      Donor Screening for Human T-Cell Lymphotrophic Virus 1/2: The future Is Uncertain (pages 199–200)

      A. Humar

      Article first published online: 24 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02970.x

      Screening of organ donors for HTLV-1/2 infection has advantages and disadvantages that must be weighed, and rational decisions will require new evidence. See minireview by Kaul et al on page 207.

    2. You have free access to this content
      Allograft Fibrosis—Unmasking the Players at the Dance (pages 201–202)

      R. B. Mannon and R. Fairchild

      Article first published online: 24 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02926.x

      New data suggest that the pleiotropic cytokine interleukin-6 may be a key contributor to allograft fibrosis through a complex interaction with connective tissue growth factor (CTGF), a downstream effector of TGF-beta. See article by Booth et al on page 220.

    3. You have free access to this content
      Pushing the Boundaries in Hepatopulmonary Syndrome (pages 203–204)

      J. G. O'Grady and J. Wendon

      Article first published online: 24 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02933.x

      Hepatopulmonary syndrome is potentially no longer a contraindication to liver transplantation when the required clinical support is delivered. See article by Gupta et al on page 354.

    4. You have free access to this content
      Immunosuppression and Heart Transplantation: How Do We Define Success? (pages 205–206)

      D. A. Baran, D. O. Taylor and J. A. Kobashigawa

      Article first published online: 24 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02885.x

      How do we balance the trade-offs between reduced rates of allograft rejection and other morbidities such as renal dysfunction, myelosuppression and non-specific graft failure? See article by Teuteberg et al on page 382.

  3. Minireviews

    1. Top of page
    2. The AJT Report
    3. Editorials
    4. Minireviews
    5. Laboratory Science
    6. Clinical Science
    7. Brief Communications
    8. Case Report
    9. Letters to the Editor
    1. You have free access to this content
      Donor Screening for Human T-cell Lymphotrophic Virus 1/2: Changing Paradigms for Changing Testing Capacity (pages 207–213)

      D. R. Kaul, S. Taranto, C. Alexander, S. Covington, M. Marvin, M. Nowicki, J. Orlowski, C. Pancoska, T. L. Pruett, M. G. Ison and for the HTLV Donor Screening Advisory Group

      Article first published online: 15 OCT 2009 | DOI: 10.1111/j.1600-6143.2009.02867.x

      HTLV-1/2 screening in the solid organ donor population is increasingly challenging: donors that are HTLV1/2 positive are infrequently used despite most results being either false positive or due to HTLV-2, which has not been associated with disease. See editorial by Humar on page 199.

    2. You have free access to this content
      Tolerogenic Dendritic Cells: All Present and Correct? (pages 214–219)

      A. W. Thomson

      Article first published online: 5 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02955.x

      Recent findings that enhance mechanistic insight into the functions of tolerogenic dendritic cells are summarized and the therapeutic potential of these antigen-presenting cells, with special reference to hematopoietic stem cell and organ transplantation, is discussed.

  4. Laboratory Science

    1. Top of page
    2. The AJT Report
    3. Editorials
    4. Minireviews
    5. Laboratory Science
    6. Clinical Science
    7. Brief Communications
    8. Case Report
    9. Letters to the Editor
    1. Original Articles

      You have free access to this content
      Connective Tissue Growth Factor Promotes Fibrosis Downstream of TGFβ and IL-6 in Chronic Cardiac Allograft Rejection (pages 220–230)

      A. J. Booth, K. Csencsits-Smith, S. C. Wood, G. Lu, K. E. Lipson and D. K. Bishop

      Article first published online: 25 SEP 2009 | DOI: 10.1111/j.1600-6143.2009.02826.x

      • image
      • image
      • image
      • image
      • image
      • image
      • image

      TGFβ and IL-6 serve as upstream contributors to connective tissue growth factor production, which in turn serves as an effector molecule of fibrosis in chronic cardiac allograft rejection. See editorial by Mannon and Fairchild on page 201.

    2. You have free access to this content
      RGS4 Controls Renal Blood Flow and Inhibits Cyclosporine-Mediated Nephrotoxicity (pages 231–241)

      A. Siedlecki, J. R. Anderson, X. Jin, J. R. Garbow, T. S. Lupu and A. J. Muslin

      Article first published online: 2 DEC 2009 | DOI: 10.1111/j.1600-6143.2009.02930.x

      • image
      • image
      • image
      • imageimage
      • image
      • image
      • image
      • image

      RGS4 deficient mice were treated with cyclosporine and found to be highly susceptible to ischemic kidney injury using a novel in vivo high resolution regional perfusion technique.

    3. You have free access to this content
      Antiinflammatory and Anticoagulant Effects of Transgenic Expression of Human Thrombomodulin in Mice (pages 242–250)

      S. Crikis, X. M. Zhang, S. Dezfouli, K. M. Dwyer, L. M. Murray-Segal, E. Salvaris, C. Selan, S. C. Robson, H. H. Nandurkar, P. J. Cowan and A. J. F. D’Apice

      Article first published online: 6 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02939.x

      • image
      • image
      • image
      • image
      • image
      • image
      • image

      Transgenic expression in mice of hTBM results in an antocoagulant and anti-inflammatory phenotype that confers survival advantages in models of transplantation, thrombosis and pulmonary embolism.

    4. You have free access to this content
      Composite Tissue Vasculopathy and Degeneration Following Multiple Episodes of Acute Rejection in Reconstructive Transplantation (pages 251–261)

      J. V. Unadkat, S. Schneeberger, E. H. Horibe, C. Goldbach, M. G. Solari, K. M. Washington, V. S. Gorantla, G. M. Cooper, A. W. Thomson and W. P. Andrew Lee

      Article first published online: 23 DEC 2009 | DOI: 10.1111/j.1600-6143.2009.02941.x

      • image
      • image
      • image
      • image
      • image
      • image
      • image

      In reconstructive transplantation, multiple acute rejections induce transplant vasculopathy preceded by increasing macrophages and fibrosis in deeper tissues, while skin changes are a late occurrence.

    5. You have free access to this content
      The Changed Balance of Regulatory and Naive T Cells Promotes Tolerance after TLI and Anti-T-Cell Antibody Conditioning (pages 262–272)

      R. G. Nador, D. Hongo, Z. Yao and S. Strober

      Article first published online: 23 DEC 2009 | DOI: 10.1111/j.1600-6143.2009.02942.x

      • image
      • image
      • image
      • image

      Mixed chimerism and tolerance to heart grafts was induced in mice conditioned with total lymphoid irradiation and anti-T cell antibodies, and tolerance was dependent upon the newly predominant host T cell subsets, Tregs and NKT cells.

    6. You have free access to this content
      Impact of Thrombocytopenia on Survival of Baboons with Genetically Modified Pig Liver Transplants: Clinical Relevance (pages 273–285)

      B. Ekser, C. Long, G. J. Echeverri, H. Hara, M. Ezzelarab, C. C. Lin, M. E. De Vera, R. Wagner, E. Klein, R. F. Wolf, D. Ayares, D. K.C. Cooper and B. Gridelli

      Article first published online: 23 DEC 2009 | DOI: 10.1111/j.1600-6143.2009.02945.x

      • image
      • imageimage
      • imageimageimageimage

      To investigate the feasibility of bridging to liver allotransplantation by orthotopic xenotransplantation, genetically-engineered pig livers were transplanted into baboons; the major limiting factor was the development of a profound thrombocytopenia.

  5. Clinical Science

    1. Top of page
    2. The AJT Report
    3. Editorials
    4. Minireviews
    5. Laboratory Science
    6. Clinical Science
    7. Brief Communications
    8. Case Report
    9. Letters to the Editor
    1. Original Articles

      You have free access to this content
      Meta-Analyses Qualify Metzincins and Related Genes as Acute Rejection Markers in Renal Transplant Patients (pages 286–297)

      S. Rödder, A. Scherer, M. Körner, U. Eisenberger, A. Hertig, F. Raulf, E. Rondeau and H.-P. Marti

      Article first published online: 2 DEC 2009 | DOI: 10.1111/j.1600-6143.2009.02928.x

      • image
      • image
      • image
      • image
      • image
      • image
      • image

      Microarray data using four studies of renal allograft biopsies qualified the extracellular matrix remodeling proteases metzincins and related genes as molecular classifiers of acute rejection, revealed uniform enrichment of 13 genes, further analyzed on protein and mRNA level, and correlated to Banff histological lesion scores

    2. You have free access to this content
      Diabetes Mellitus: A Risk Factor for Delayed Graft Function after Deceased Donor Kidney Transplantation (pages 298–303)

      J. Parekh, A. Bostrom and S. Feng

      Article first published online: 6 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02936.x

      Recipient diabetes mellitus is a highly significant risk factor for delayed graft function after deceased donor kidney transplantation, according to United Network for Organ Sharing data.

    3. You have free access to this content
      Efficient Utilization of the Expanded Criteria Donor (ECD) Deceased Donor Kidney Pool: An Analysis of the Effect of Labeling (pages 304–309)

      R. A. Hirth, Q. Pan, D. E. Schaubel and R. M. Merion

      Article first published online: 6 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02937.x

      • image
      • image

      The creation of a specific definition of an Expanded Criteria Donor for kidney transplantation corresponded to changes in number of such donors acquired and likelihood of use of such organs.

    4. You have free access to this content
      Clinical Predictors of Proteinuria after Conversion to Sirolimus in Kidney Transplant Recipients (pages 310–314)

      A. Padiyar, K. A. Bodziak, D. E. Hricik and J. J. Augustine

      Article first published online: 6 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02940.x

      • image
      • image

      This study analyzing outcomes after early conversion from tacrolimus to sirolimus therapy in stable kidney transplant patients showed that African Americans had a high rate of increased proteinuria after conversion.

    5. You have free access to this content
      Histopathologic Clusters Differentiate Subgroups Within the Nonspecific Diagnoses of CAN or CR: Preliminary Data from the DeKAF Study (pages 315–323)

      A. J. Matas, R. Leduc, D. Rush, J. M. Cecka, J. Connett, A. Fieberg, P. Halloran, L. Hunsicker, F. Cosio, J. Grande, R. Mannon, S. Gourishankar, R. Gaston and B. Kasiske

      Article first published online: 23 DEC 2009 | DOI: 10.1111/j.1600-6143.2009.02943.x

      • image
      • image
      • image
      • image

      Cluster analysis based on Banff score components distinguishes meaningful subgroups with differing outcomes.

    6. You have free access to this content
      Pathological and Clinical Characterization of the ‘Troubled Transplant’: Data from the DeKAF Study (pages 324–330)

      S. Gourishankar, R. Leduc, J. Connett, J. M. Cecka, F. Cosio, A. Fieberg, R. Gaston, P. Halloran, L. Hunsicker, B. Kasiske, D. Rush, J. Grande, R. Mannon and A. Matas

      Article first published online: 5 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02954.x

      • image
      • image

      In kidney allograft biopsy for new onset late dysfunction, local diagnosis of CAN is of no prognostic significance.

    7. You have free access to this content
      Diabetes after Kidney Donation (pages 331–337)

      H. N. Ibrahim, A. Kukla, G. Cordner, R. Bailey, K. Gillingham and A. J. Matas

      Article first published online: 23 DEC 2009 | DOI: 10.1111/j.1600-6143.2009.02944.x

      • image

      Kidney donors who develop diabetes are more likely to have hypertension and proteinuria than non-diabetic donors but the rate of eGFR change is not accelerated.

    8. You have free access to this content
      Predicting Coronary Heart Disease after Kidney Transplantation: Patient Outcomes in Renal Transplantation (PORT) Study (pages 338–353)

      A. K. Israni, J. J. Snyder, M. A. Skeans, Y. Peng, J. R. Maclean, E. D. Weinhandl, B. L. Kasiske and for the PORT Investigators

      Article first published online: 24 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02949.x

      • image
      • image
      • image
      • imageimageimage
      • image

      Data from an international, multicenter consortium were collected to develop equations that predict coronary heart disease risk after kidney transplantation.

    9. You have free access to this content
      Improved Survival After Liver Transplantation in Patients with Hepatopulmonary Syndrome (pages 354–363)

      S. Gupta, H. Castel, R. V. Rao, M. Picard, L. Lilly, M. E. Faughnan and G. Pomier-Layrargues

      Article first published online: 22 SEP 2009 | DOI: 10.1111/j.1600-6143.2009.02822.x

      • image

      This series shows a higher survival post-liver transplant in patients with hepatopulmonary syndrome (HPS), and severe HPS in particular, compared to prior reports. See editorial by O'Grady and Wendon on page 203.

    10. You have free access to this content
      Adult Living Liver Donors have Excellent Long-Term Medical Outcomes: The University of Toronto Liver Transplant Experience (pages 364–371)

      L. Adcock, C. Macleod, D. Dubay, P. D. Greig, M. S. Cattral, I. McGilvray, L. Lilly, N. Girgrah, E. L. Renner, M. Selzner, N. Selzner, A. Kashfi, R. Smith, S. Holtzman, S. Abbey, D. R. Grant, G. A. Levy and G. Therapondos

      Article first published online: 24 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02950.x

      • image

      Living liver right lobe donors have excellent long term medical outcomes with few complications after one year.

    11. You have free access to this content
      Hypothermic Machine Preservation in Human Liver Transplantation: The First Clinical Series (pages 372–381)

      J. V. Guarrera, S. D. Henry, B. Samstein, R. Odeh-Ramadan, M. Kinkhabwala, M. J. Goldstein, L. E. Ratner, J. F. Renz, H. T. Lee, R. S. Brown, Jr. and J. C. Emond

      Article first published online: 2 DEC 2009 | DOI: 10.1111/j.1600-6143.2009.02932.x

      • image
      • image
      • image
      • image
      • image

      This report is the first clinical experience with human liver machine preservation for transplantation.

    12. You have free access to this content
      Alemtuzumab Induction Prior to Cardiac Transplantation with Lower Intensity Maintenance Immunosuppression: One-Year Outcomes (pages 382–388)

      J. J. Teuteberg, M. A. Shullo, R. Zomak, Y. Toyoda, D. M. McNamara, C. Bermudez, R. L. Kormos and K. R. McCurry

      Article first published online: 4 NOV 2009 | DOI: 10.1111/j.1600-6143.2009.02856.x

      • image
      • image

      Induction therapy after cardiac transplantation with alemtuzumab in combination with lower dose maintenance immunosuppression without steroids results in similar survival but greater freedom from rejection at one year compared to historical controls. See editorial by Baran et al on page 205.

    13. You have free access to this content
      Equivalent Outcomes for Pediatric Heart Transplantation Recipients: ABO-Blood Group Incompatible versus ABO-Compatible (pages 389–397)

      A. I. Dipchand, S. M. Pollock BarZiv, C. Manlhiot, L. J. West, M. VanderVliet and B. W. McCrindle

      Article first published online: 23 DEC 2009 | DOI: 10.1111/j.1600-6143.2009.02934.x

      • image
      • image
      • image

      Comparison of two contemporary pediatric populations who received either ABO-compatible or ABO-incompatible heart transplants found that medium-term outcomes were indistinguishable, and the use of ABO-incompatible listing improved waitlist survival.

    14. You have free access to this content
      Incidence of and Risk Factors for Posttransplant Diabetes Mellitus after Pancreas Transplantation (pages 398–406)

      N. Neidlinger, N. Singh, C. Klein, J. Odorico, A. Munoz del Rio, Y. Becker, H. Sollinger and J. Pirsch

      Article first published online: 6 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02935.x

      • image
      • image

      In this single-center study of nearly 700 pancreas transplant (PTX) recipients with long-term follow up, the incidence of post transplant diabetes mellitus (PTDM) was 25% at 10-years after PTX.

    15. You have free access to this content
      BK-Virus and the Impact of Pre-Emptive Immunosuppression Reduction: 5-Year Results (pages 407–415)

      K. L. Hardinger, M. J. Koch, D. J. Bohl, G. A. Storch and D. C. Brennan

      Article first published online: 5 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02952.x

      • image
      • image
      • image

      Five year follow-up of preemptive withdrawal of immunosuppression upon detection of BK-viremia was associated with excellent graft survival, low rejection rates, excellent renal function, and freedom from clinically evident BK-virus nephropathy.

  6. Brief Communications

    1. Top of page
    2. The AJT Report
    3. Editorials
    4. Minireviews
    5. Laboratory Science
    6. Clinical Science
    7. Brief Communications
    8. Case Report
    9. Letters to the Editor
    1. You have free access to this content
      Centers for Disease Control ‘High-Risk’ Donors and Kidney Utilization (pages 416–420)

      K. I. Duan, M. J. Englesbe and M. L. Volk

      Article first published online: 2 DEC 2009 | DOI: 10.1111/j.1600-6143.2009.02931.x

      • image

      Kidneys from CDC High Risk donors were less likely to be used for transplantation than kidneys from non-CDC High Risk donors, despite being associated with similar patient survival.

    2. You have free access to this content
      Cluster Analysis of Lesions in Nonselected Kidney Transplant Biopsies: Microcirculation Changes, Tubulointerstitial Inflammation and Scarring (pages 421–430)

      B. Sis, G. Einecke, J. Chang, L. G. Hidalgo, M. Mengel, B. Kaplan and P. F. Halloran

      Article first published online: 6 JAN 2010 | DOI: 10.1111/j.1600-6143.2009.02938.x

      • image
      • image
      • image
      • image
      • image

      Class discovery approach identifies robust lesion groups in non-selected kidney transplant biopsies and confirms most assumptions on which diagnoses are assigned by the Banff classification, but suggests new interpretations of some lesions.

  7. Case Report

    1. Top of page
    2. The AJT Report
    3. Editorials
    4. Minireviews
    5. Laboratory Science
    6. Clinical Science
    7. Brief Communications
    8. Case Report
    9. Letters to the Editor
    1. You have free access to this content
      A Case of Human Intramuscular Adrenal Gland Transplantation as a Cure for Chronic Adrenal Insufficiency (pages 431–433)

      E. Grodstein, M. A. Hardy and M. J. Goldstein

      Article first published online: 2 DEC 2009 | DOI: 10.1111/j.1600-6143.2009.02929.x

      • image

      A case of human intramuscular adrenal gland transplantation as a cure for chronic adrenal insufficiency.

  8. Letters to the Editor

    1. Top of page
    2. The AJT Report
    3. Editorials
    4. Minireviews
    5. Laboratory Science
    6. Clinical Science
    7. Brief Communications
    8. Case Report
    9. Letters to the Editor
    1. You have free access to this content
    2. You have free access to this content

SEARCH

SEARCH BY CITATION